Journal of Precision Biosciences
Biopharmaceuticals and medical sciences | Online ISSN 3064-9226
  1. You are here:
  2. Home
  3. Journals
  4. Biological Sciences
LETTERS   (Open Access)
Contents Vol 1 (1)

Regenerative Medicine Revolution By Personalized Design

John Catanzaro 1*, Andrew Dickens 2*
 

+ Author Affiliations

Journal of Precision Biosciences 1 (1) 1-3 https://doi.org/10.25163/biosciences.112088LET112921119

Submitted: 11 October 2019 Revised: 29 October 2019  Published: 02 November 2019 

Abstract

Regenerative medicine and personalized therapies are redefining healthcare by emphasizing tailored approaches that treat individuals rather than diseases. This shift has proven particularly advantageous in cancer and autoimmune treatments, achieving significant success rates with personalized immune-based therapies. Methods such as the innovative Precision-Based Immuno-Molecular Augmentation (PBIMA) have demonstrated remarkable efficacy in patients who were considered incurable by conventional standards. Despite facing professional challenges and criticism from established medical institutions, these approaches have garnered strong support from patients who have experienced life-saving outcomes. The field of personalized medicine is advancing through collaboration with biointelligence companies, leveraging genomic and proteomic data to create individualized treatment plans that minimize side effects and enhance patient outcomes. This discussion explores the principles, clinical applications, and future directions of personalized regenerative therapies, underscoring their transformative potential in modern healthcare.

References

 Burstein, H. J., Krilov, L., Aragon-Ching, J. B., et al. (2022). American Society of Clinical Oncology Policy Statement Update: The Role of Clinical Cancer Research in the Development of Health Care Policy. Journal of Clinical Oncology, 40(7), 755-767.

Califf, R. M., & Collins, F. S. (2021). The future of precision medicine. New England Journal of Medicine, 385(3), 225-235.

Catanzaro, J. A. (2015). Integrative approaches to cancer treatment. Journal of Naturopathic Oncology, 7(4), 67-75.

Catanzaro, J. A. (2018). Personalized cancer therapy: New frontiers. Journal of Personalized Medicine, 8(2), 45.

Catanzaro, J. A. (2021). Neo7Logix: Innovating healthcare through biointelligence. Journal of Precision Medicine, 10(3), 159-167.

Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793-795.

Dey, S., Tripathy, S., & Mandal, S. (2020). Advances in personalized medicine for cancer. Cancer Research and Treatment, 52(1), 23-34.

Dzau, V. J., Ginsburg, G. S., & Van der Wees, P. J. (2016). Accelerating the implementation of precision medicine. Journal of the American Medical Association, 315(17), 1851-1852.

Faden, R. R. (2019). The ethics of the right-to-try movement. Journal of Medical Ethics, 45(3), 161-165.

Gupta, A., Kumar, S., & Singh, R. (2023). Personalized medicine: Current status and future perspectives. Journal of Translational Medicine, 21(1), 1-10.

Harrington, S. E. (2016). The personalized medicine revolution: Drug and device development. New England Journal of Medicine, 375(22), 2173-2175.

Jameson, J. L., & Longo, D. L. (2015). Precision medicine — personalized, problematic, and promising. New England Journal of Medicine, 372(23), 2229-2234.

Khosla, S. (2017). The potential of right-to-try laws in precision medicine. Bioethics, 31(8), 634-642.

Lu, Y., Sun, W., & Lin, C. (2021). Personalized cancer vaccines: The next frontier. Journal of Cancer, 12(14), 4195-4201.

Mason, C., & Dunnill, P. (2008). A brief definition of regenerative medicine. Regenerative Medicine, 3(1), 1-5.

McCarthy, J. J., McLeod, H. L., & Ginsburg, G. S. (2019). Personalized medicine for the oncology patient. Journal of Clinical Oncology, 37(6), 496-507.

Naylor, C. D., & Woolf, S. H. (2013). Global health — measuring the world’s “forgotten burden” of disease. New England Journal of Medicine, 369(9), 837-839.

Schork, N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609-611.

Sun, W. (2022). Advances in personalized oncology. Journal of Clinical Medicine, 11(3), 326.

Tan, D. S., Mok, T., & Rebbeck, T. R. (2020). Personalized medicine in oncology: Practice and promise. Journal of Clinical Oncology, 38(9), 2022-2030.

Trounson, A., & McDonald, C. (2015). Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell, 17(1), 11-22.

Woolf, S. H. (2008). The power of prevention and what it requires. Journal of the American Medical Association, 299(20), 2437-2439.

Yu, P. P., Wilemon, K. A., & Angove, R. S. (2019). The evolution of personalized medicine: New paradigms and perspectives. Journal of Personalized Medicine, 9(2), 1-15.

Yuryev, A., Catanzaro, J. A., & Venter, J. C. (2020). Biointelligence for precision health care. Nature Biotechnology, 38(8), 923-925.

Zhang, X., Huang, Y., & Yu, H. (2021). Personalized medicine in the new era of healthcare. Clinical and Translational Medicine, 11(6), e411.

 

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric




Save
0
Citation
800
View

Share